Caricamento...
Hepatitis C virus: A time for decisions. Who should be treated and when?
Cirrhosis is the most important risk factor for hepatocellular carcinoma (HCC) regardless of the etiology of cirrhosis. Compared to individuals who are anti-hepatitis C virus (HCV) seronegative, anti-HCV seropositive individuals have a greater mortality from both hepatic as well as nonhepatic diseas...
Salvato in:
| Pubblicato in: | World J Gastrointest Pharmacol Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734952/ https://ncbi.nlm.nih.gov/pubmed/26855810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v7.i1.33 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|